Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: silica

May 4, 2026 Environmental / Non-pharma applications

CDs for the removal of PFAS; A review

Per- and polyfluoroalkyl substances, known as ‘forever pollutants’ due to their very high stability in ecosystems, are industrial contaminants of

Continue reading

February 20, 2024 Analysis / Food / Non-pharma applications

Cyclodextrins-based sorbents for sustainable sample preparation focusing on food analysis

Food analysis is critical for ensuring human health and safety, as it involves the detection of contaminants such as pesticides,

Continue reading

January 23, 2024 CD derivatives / Environmental / Non-pharma applications / Pharma applications

Silica–Cyclodextrin Hybrid Materials: Two Possible Synthesis Processes

Both cyclodextrin (CD) and porous silica possess interesting properties of adsorption and release. A silica–CD hybrid, therefore, could synergically merge

Continue reading

February 8, 2022 CD derivatives / Environmental / Non-pharma applications

Recycling rare earth elements from industrial sludge using green leaching agents and porous β-cyclodextrin polymer composite

This study reported the green approaches for recycling REEs from industrial sludge using environmentally friendly extracting solutions (NH4)2SO4, GLDA, TBAB,

Continue reading

August 1, 2018 Drug delivery / E-ducation / Environmental / Non-pharma applications / Pharma applications

New books on cyclodextrins

Three new books on various aspects of cyclodextrin research and applications have been recently published. 1. Cyclodextrin Fundamentals, Reactivity and

Continue reading

Recent Posts

  • Special Issue titled “Cyclodextrins: Properties and Applications, 4th Edition”
  • Cyclodextrins hit the golf course seven years ago — and they are still there
  • Enhancing Curcumin Efficacy Against Triple-Negative Breast Cancer
  • REVTORPYK™: A New FDA Approval for Gedatolisib/HPBCD composition
  • Reducing Cholesterol with β-CDP: Insights for NPC and AD

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (73)
  • CD as API (355)
  • CD derivatives (431)
  • Cosmetics and toilettry (54)
  • Diagnosis (15)
  • Drug delivery (816)
  • E-ducation (63)
  • Environmental (143)
  • Events (239)
  • Food (233)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (45)
  • Non-pharma applications (416)
  • Other industrial use (112)
  • Pharma applications (1,219)
  • Supramolecular systems (44)
  • Uncategorized (167)

Top Posts

  • Special Issue titled "Cyclodextrins: Properties and Applications, 4th Edition"
  • Cyclodextrins hit the golf course seven years ago — and they are still there
  • REVTORPYK™: A New FDA Approval for Gedatolisib/HPBCD composition
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies
  • Cyclarity Unveils First-Ever Clinical Data Demonstrating Excretion of Oxidized Cholesterol, at American Heart Association Vascular Discovery Scientific Sessions
  • Enhancing Curcumin Efficacy Against Triple-Negative Breast Cancer
  • Lanosterol eye drops for cataract treatment
  • Cyclodextrins against skin aging
  • Amgen Submits Supplemental New Drug Application For KYPROLIS® (carfilzomib)
  • Cyclodextrins and derivatives in drug delivery: New developments, relevant clinical trials, and advanced products

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,476 other subscribers
Loading Comments...